Page 58 - Pro-active Management of Women’s Health after Cardiometabolic Complicated Pregnancies
P. 58
56 | Part 2 Cardiovascular Health
preeclampsia in thrombophilic women with acquired thrombophilia like anti- phospholipid syndrome are currently being conducted.
In conclusion, phenotyping of preeclampsia can help to determine if screening for thrombophilia is warranted. We advise to screen for anti- phospholipid antibodies after early onset preeclampsia, especially if complicated by IUGR. We do not recommend routine screening for thrombophilia and screening after other phenotypes of preeclampsia. We suggest that enough evidence is presented to conclude that associations between preeclampsia and thrombophilia are not clinically important and further studies should not be conducted.
